Overview
Mateo Mejia-Saldarriaga is a Hematologist Oncology specialist and an Oncologist in New York, New York. Dr. Mejia-Saldarriaga is rated as an Experienced provider by MediFind in the treatment of Glucose-6-Phosphate Dehydrogenase Deficiency. His top areas of expertise are Smoldering Multiple Myeloma, Angioimmunoblastic T-cell Lymphoma, Multiple Myeloma, and Lymphofollicular Hyperplasia.
His clinical research consists of co-authoring 7 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Glucose-6-Phosphate Dehydrogenase Deficiency.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
520 E 70th St, New York, NY 10021
425 E 61st St, Fl 4, New York, NY 10065
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Eduardo Saponara is a Hematologist Oncology specialist and a Hematologist in Bronxville, New York. Dr. Saponara is rated as an Advanced provider by MediFind in the treatment of Glucose-6-Phosphate Dehydrogenase Deficiency. His top areas of expertise are Chronic T-Cell Leukemia (CTCL), Adult T-Cell Leukemia, Glucose-6-Phosphate Dehydrogenase Deficiency, and Chronic B-Cell Leukemia (CBCL).
New York University
Boris Kobrinsky is a Hematologist Oncology specialist and an Oncologist in New York, New York. Dr. Kobrinsky is rated as an Advanced provider by MediFind in the treatment of Glucose-6-Phosphate Dehydrogenase Deficiency. His top areas of expertise are Anemia, Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, and Pleuropulmonary Blastoma.
New York University
Gerard Donnelly is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Donnelly is rated as a Distinguished provider by MediFind in the treatment of Glucose-6-Phosphate Dehydrogenase Deficiency. His top areas of expertise are Hereditary Resistance to Anti-Vitamin K, Protein C Deficiency, Protein S Deficiency, and Congenital Antithrombin 3 Deficiency.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Smoldering Multiple MyelomaDr. Mejia-Saldarriaga isAdvanced. Learn about Smoldering Multiple Myeloma.
- Experienced
- Adult T-Cell LeukemiaDr. Mejia-Saldarriaga isExperienced. Learn about Adult T-Cell Leukemia.
- Angioimmunoblastic T-cell LymphomaDr. Mejia-Saldarriaga isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- Atypical Hemolytic Uremic Syndrome (aHUS)Dr. Mejia-Saldarriaga isExperienced. Learn about Atypical Hemolytic Uremic Syndrome (aHUS).
- D-Plus Hemolytic Uremic SyndromeDr. Mejia-Saldarriaga isExperienced. Learn about D-Plus Hemolytic Uremic Syndrome.
- Glucose-6-Phosphate Dehydrogenase DeficiencyDr. Mejia-Saldarriaga isExperienced. Learn about Glucose-6-Phosphate Dehydrogenase Deficiency.
- Hemolytic-Uremic SyndromeDr. Mejia-Saldarriaga isExperienced. Learn about Hemolytic-Uremic Syndrome.